Valuation: Apeloa Pharmaceutical Co.,Ltd

Market Cap 24.14B 3.61B 3.24B 2.96B 2.7B 5.1B 340B 5.26B 35.71B 14.24B 181B 13.57B 13.28B 572B P/E 2026 *
24.9x
P/E 2027 * 20.3x
Enterprise Value 23.48B 3.52B 3.15B 2.88B 2.63B 4.96B 330B 5.11B 34.73B 13.85B 176B 13.2B 12.91B 557B EV / Sales 2026 *
2.55x
EV / Sales 2027 * 1.95x
Free-Float
45.17%
Yield 2026 *
1.4%
Yield 2027 * 1.58%
1 day-2.63%
1 week+10.89%
Current month+10.89%
1 month-22.57%
3 months-8.24%
6 months+23.09%
Current year+32.02%
1 week 19.06
Extreme 19.06
22.66
1 month 18.71
Extreme 18.71
27.17
Current year 15.19
Extreme 15.19
28.5
1 year 15.19
Extreme 15.19
28.5
3 years 10.66
Extreme 10.66
28.5
5 years 10.66
Extreme 10.66
41.87
10 years 4.86
Extreme 4.86
41.87
Manager TitleAgeSince
Chief Executive Officer 54 -
President 52 -
Director of Finance/CFO 54 -
Director TitleAgeSince
Director/Board Member 60 2005-04-14
Director/Board Member 61 2008-05-15
Chairman 54 2017-11-06
Date Insider Type Main position Quantity % Market Cap. Importance
4/26/23 Sell

Chief Executive Officer

6,200 0.0005%
6/28/22 Buy 50,000 0.0042%
6/28/22 Buy

Director

100,000 0.0085%
Change 5-day change 1-year change 3-year change Capi.($)
-2.63%+10.89%+41.04%+26.35% 3.61B
-0.79%-4.48%+46.48%+125.69% 1,206B
+1.43%+1.11%+48.05%+83.05% 665B
+1.07%-1.21%+32.92%+104.92% 515B
-0.36%-3.25%+45.42%+65.10% 381B
-0.14%-1.87%+70.06%+41.09% 362B
-0.78%-0.52%+30.47%+58.09% 307B
-0.80%-0.21%+7.98%+36.17% 289B
+0.03%-1.20%+43.79%+69.83% 249B
-0.41%-2.22%+40.43%+107.03% 207B
Average -0.34%-0.70%+40.66%+71.73% 418.34B
Weighted average by Cap. -0.05%-1.95%+42.71%+88.06%

Financials

2026 *2027 *
Net sales 9.22B 1.38B 1.24B 1.13B 1.03B 1.95B 130B 2.01B 13.65B 5.44B 69.28B 5.18B 5.07B 219B 10.4B 1.56B 1.4B 1.28B 1.17B 2.2B 146B 2.27B 15.39B 6.14B 78.13B 5.85B 5.72B 247B
Net income 1B 150M 135M 123M 112M 212M 14.12B 218M 1.48B 592M 7.54B 564M 552M 23.79B 1.23B 183M 165M 150M 137M 259M 17.25B 267M 1.81B 723M 9.2B 689M 674M 29.05B
Net Debt -659M -98.74M -88.56M -80.93M -73.88M -139M -9.28B -144M -976M -389M -4.95B -371M -363M -15.63B -3.85B -576M -517M -472M -431M -812M -54.17B -838M -5.69B -2.27B -28.91B -2.16B -2.12B -91.26B
Projected Income Statement - Annual - Apeloa Pharmaceutical Co.,Ltd
Logo Apeloa Pharmaceutical Co.,Ltd
Apeloa Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Active Pharmaceutical Ingredient (API) intermediates, contract development and manufacturing organization (CDMO), preparations and others, as well as import and export trade. The Company operates three businesses. The API intermediates business mainly includes cephalosporin series, penicillin series, psychiatric series, cardiovascular and cerebrovascular series and veterinary API intermediates series. The CDMO business mainly includes research and development services, commercial human drug projects, commercial veterinary drug projects and other commercial products. The preparation business mainly includes anti-infective, cardiovascular and cerebrovascular, psychiatric and anti-tumor preparation products. The Company mainly operates its businesses in domestic and overseas markets.
Employees
6,787
Date Price Change Volume
26-11-06 CN¥21.48 -2.63% 8,318,124
26-11-05 CN¥22.06 +2.22% 14,512,671
26-11-04 CN¥21.58 +5.06% 14,272,000
26-11-03 CN¥20.54 +2.19% 15,659,591
26-11-02 CN¥20.10 +3.77% 17,562,694
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Apeloa Pharmaceutical Co.,Ltd
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
21.48CNY
Average target price
26.67CNY
Spread / Average Target
+24.15%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Apeloa Pharmaceutical Co.,Ltd
  1. Stock Market
  2. Stocks
  3. 000739 Stock